The prevalence of parenteral hepatitis markers among the medical personnel in the Russian Federation regions with different intensity of epidemic process | CMAC

The prevalence of parenteral hepatitis markers among the medical personnel in the Russian Federation regions with different intensity of epidemic process

Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(2):161-167

​ Nikitina G.Yu., Semenenko T.A., Gotvyanskaya T.P., Hahaeva I.B., Konopleva M.V., Nikolaeva O.G., Yarosh L.V., Kozhevnikova L.K., Suslov A.P.
hospital staff vaccination hepatitis B hepatitis C HBsAg subtypes
Section
Personal Experience
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(2):161-167

Abstract

The results of hepatitis markers prevalence estimation and the immune response intensity and duration in hospital staff (Buryatiya, Ulan-Ude, n=611 and Moscow, n=653) after vaccination against hepatitis B are presented. HBV serological markers were revealed in 259 (42.5%) and 70 (11.7%) persons: HBsAg (2.6% versus 0.2%; p<0.05), anti-HBs in a combination with anti-HBc (35.0% versus 10.7%; p<0.05), only anti-HBc (4.9% versus 0.8%; p<0.05) among Ulan-Ude and Moscow medical personnel, respectively. HBV DNA positive in PCR isolates had genotype D (90.9%), subtypes ayw3 and ayw2. HBV genotype D has been established in 90.9% of isolates and genotype A in 9.1% (Ulan-Ude). Prevalence of subtypes HBsAg in our research was 9.1% (ad) and (90.9% (ay). Anti-HCV were revealed in 3.3% and 2.9%, HCV RNA – in 41.2% and 36.8%, genotype 1 HCV – in 57.1% and 85.7%, genotype 3 HCV in 28.6% and 14.3% of cases in Ulan-Ude and Moscow, respectively. The question of the selection of vaccines with dominant among the population of Russia HBsAg subtype ay for the improvement of immunization programs is discussed.

Galina Yu. Nikitina

S.P. Botkin City Clinical Hospital, Moscow, Russia

Tatyana A. Semenenko

FSRC of Epidemiology and Microbiology named after N.F.Gamaleya, Moscow, Russia
I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Gotvyanskaya T.P.

FSRC of Epidemiology and Microbiology named after N.F.Gamaleya, Moscow, Russia

Hahaeva I.B.

The administration of Rospotrebnadzor in the Republic of Buryatia, Ulan-Ude, Russia

Konopleva M.V.

FSRC of Epidemiology and Microbiology named after N.F.Gamaleya, Moscow, Russia

Nikolaeva O.G.

FSRC of Epidemiology and Microbiology named after N.F.Gamaleya, Moscow, Russia

Yarosh L.V.

FSRC of Epidemiology and Microbiology named after N.F.Gamaleya, Moscow, Russia

Kozhevnikova L.K.

FSRC of Epidemiology and Microbiology named after N.F.Gamaleya, Moscow, Russia

Suslov A.P.

FSRC of Epidemiology and Microbiology named after N.F.Gamaleya, Moscow, Russia

  • 1. The resolution of the Chief state sanitary doctor of the Russian Federation dated 11 March 2013 №9 Moscow «About measures aimed at stabilization of the incidence of parenteral viral hepatitis in the Russian Federation». Russian newspaper. Federal issue No. 6103. 2013. Russian.
  • 2. WHO, Fact sheet No 204, No 164, 2014.
  • 3. Kosakowska I.I., Volchkova E.V. Medico-social aspects of viral hepatitis with parenteral transmission. Jepidemiologija i infekcionnye bolezni. 2013;1:28- 39. Russian.
  • 4. Akimkin V.G, Semenenko T.A., Nikitina G.Y., Godkov M. A., Skvortsov S.V. Epidemiology of hepatitis B and C in health care settings. M.: OOO «Publishing house «Bionika», 2013. 216 p. Russian.
  • 5. Nikitina G.Y., Yarosh L.V., Sipacheva N.B., Semenenko T.A. Viral hepatitis B and C in a multidisciplinary hospital. Aktual’nye voprosy jepidemiologii infekcionnyh boleznej. 2011;10:470-476. Russian.
  • 6. Semina N.A., Kovaleva E.P., Akimkin V.G., Selkova E.P., Khrapunova I.A. Prevention of nosocomial infections in medical personnel. M.: 2006. 152 p. Russian.
  • 7. Semenenko T.A. Hepatitis B: risk to health care workers. Medicinskaja sestra. 2000;3:35-39. Russian.
  • 8. Shakhgildyan I.V., Mikhailov M.I., Onishchenko G.G. Parenteral viral hepatitis. M.: GOU VUNMC MZ RF, 2003. 383 p. Russian.
  • 9. Federal center of hygiene and epidemiology. Infectious morbidity in subjects of the Russian Federation for 1999-2011 statistical Information and analysis, part 2, Moscow, 2011. Russian.
  • 10. Silchenko E.V. Clinical and epidemiological features of chronic HBV and HCV infections in the Republic of Buryatia. PhD Thesis: Irkutsk, 2010. 22 p. Russian.
  • 11. Federal center of hygiene and epidemiology. Infectious morbidity in subjects of the Russian Federation in 2012-2013 years. Collection of statistical information and analysis, part 2, Moscow, 2013. Russian.
  • 12. Nikolaeva, L.I., Zverev S.I., Petrova E.V., et al. Humoral response to antigens of HCV in coinfection by human immunodeficiency virus 1 type. Laboratornaja diagnostika. 2008;7:42-45. Russian.
  • 13. Pimenov N.N., Chulanov V.P., Komarova S.V., et al. Hepatitis C in Russia: Epidemiological characteristics and ways of improving diagnosis and surveillance. Jepidemiologija i infekcionnye bolezni. 2012;3:4-9. Russian.
  • 14. Samokhvalov E.I., Nikolaeva L.I., Olhovskiy S.V., et al. The frequency of certain subtypes of hepatitis C virus in the Moscow region. Voprosy virusologii. 2013;58(1):36-40. Russian.
  • 15. Zherbanova L.V. Epidemiology of viral hepatitis C in the Republic of Buryatia and some aspects of pathogenesis of chronic HCV infection. PhD Thesis: Irkutsk, 2002. 18 p. Russian.
  • 16. Prokofieva T.D. Epidemiological features and molecular diagnosis of HCV, HGV and TTV infections. PhD Thesis: Irkutsk, 2005. 18 p. Russian.
  • 17. Raimondo G., Allain J.P., Brunetto M.R., et.al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49:652- 657.
  • 18. Semenenko T.A., Suslov A.P. Immunopathogenesis of occult infection caused by hepatitis B virus. Zhurnal mikrobiologii, jepidemiologii i immunobiologii. 2015;6:105-113. Russian.
  • 19. Torbenson M., Thomas D. Occult hepatitis B. Lancet Infect Dis. 2002;2(8):479-486.
  • 20. Chulanov V. Epidemiological and clinical value of hepatitis A and B viruses genetical heterogeneity. PhD Thesis: M., 2013. 46 p. Russian.
  • 21. Zabelin N.N. Genetic variability of hepatitis b virus by PreS1/PreS2/S genes in patients with chronic HB viral infection. PhD Thesis: M., 2009. 23 p. Russian.
  • 22. Yarosh L.V. Epidemiological characteristics of HBsAg mutants and occult forms of hepatitis B among different population groups. PhD Thesis: M., 2013. 21 p. Russian.
  • 23. Semenenko T.A., Nikitina G.Y., Yarosh L.V., et al. Serological and molecularbiological analysis of the medical staff vaccination against hepatitis В. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2015;17(1):73- 78. Russian.
  • 24. Shulgina N.I., Stasenko V.L. Estimation of the duration and intensity of post-vaccination humoral immunity to hepatitis B virus among decreed groups. Jepidemiologija i vakcinoprofilaktika. 2011;1(56):68-73. Russian.
  • 25. Semenenko T.A. Immune response after vaccination against hepatitis B in immunocompromised persons. Jepidemiologija i vakcinoprofilaktika. 2011;1(56):51-58. Russian.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared